HVTN 807

Phase 1, HIV

This study is assessing an experimental vaccine in combination with an antiretroviral analytical treatment interruption (ATI) in people living with HIV, to better understand the immune responses of people living with HIV after receiving an experimental vaccine, which could help scientists develop a vaccine to prevent HIV.

This study is currently enrolling participants between the ages of 18-60.

Name*
First Last
Email*
Phone*
Consent
I would like to receive information on other Center for Virology and Vaccine Research studies.
Which study are you interested in?*
How did you hear about this study?*
If you learned about our study through other means, please specify here.
Preferred method of contact*
- Phone
- Email
- Either
CAPTCHA

HVTN 807

Center for Virology and Vaccine Research

CVVR Clinical Trials Unit

Affiliates